about
Mesoglycan: clinical evidences for use in vascular diseases.Normal values for segmental bioimpedance spectroscopy in pediatric patientsHealthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants.Post-thrombotic syndrome: a clinical review.Prevention and treatment of the post-thrombotic syndrome and of the chronic thromboembolic pulmonary hypertension.Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome.The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial.Timing and duration of compression therapy after deep vein thrombosis.Clinical relevance of fibrin fiber diameter during different phases of pregnancy.
P2860
Q34340567-461A3532-9120-4D3F-9D52-2FC5A1B0400CQ35391458-6D9EF8BD-E4C0-434C-B71D-3DE396B9A666Q37955199-3915185E-445E-4BFC-83C1-DBED7369FBF7Q38083878-9C1FA661-A6D7-44C5-BDA4-B313CF6C00CDQ38314092-D2279477-21EB-4F00-B69B-A51841505A0CQ39611973-36554230-8C3D-4AFB-B5A0-FA5F8E855988Q42869565-AFB6B18D-D249-4A4F-9440-EFC1FB3EEBB0Q51733966-29939E64-1C3E-42FF-8FD7-6BD7A7858CD4Q53062826-509DBE68-A468-432D-8EA3-FE91B3721206
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The postthrombotic syndrome.
@en
The postthrombotic syndrome.
@nl
type
label
The postthrombotic syndrome.
@en
The postthrombotic syndrome.
@nl
prefLabel
The postthrombotic syndrome.
@en
The postthrombotic syndrome.
@nl
P2093
P2860
P1476
The postthrombotic syndrome.
@en
P2093
Paolo Prandoni
Raffaele Pesavento
Sabina Villalta
P2860
P2888
P304
P356
10.1007/S11739-009-0336-2
P577
2009-12-10T00:00:00Z